PGP and neoplasm: In addition, (Bai et al., 2013) reported that nanoparticle-mediated drug delivery to the tumor neovasculature was able to overcome P-gp-expressing multidrug resistant cancer by targeting KDR receptors, which are highly expressed in the tumor vasculature.